{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:16:08Z","timestamp":1790496968414,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepcidin, a key regulator of iron metabolism, is expressed in the liver, distributed in blood, and excreted in urine. However, to date, no reliable and practical method for measuring the bioactive form of hepcidin in serum has been developed. Here, we used surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF MS) to analyze the distinctive serum proteomic patterns of patients receiving hemodialysis. In the range of 1000 to 15 000 m\/z, we found 3 peptides at 2192, 2789, and 2851 m\/z that showed a significant correlation with the serum ferritin levels. The molecular sizes of peptides at 2192 and 2789 m\/z matched with the reported sizes of hepcidin-20 and -25, respectively, and the serum peptide at 2789 m\/z was identified as hepcidin-25 by collision-induced dissociation tandem MS. By using SELDI-TOF MS, we developed a semiquantitative assay for hepcidin-25. In this assay, the level of serum hepcidin-25 correlated well with levels of serum ferritin and serum interleukin-6. Hepcidin-25 was found to accumulate in the serum of patients receiving hemodialysis; this could contribute to the pathogenesis of renal anemia by decreasing the available iron for hematopoiesis. Thus, SELDI-TOF MS would be a clinically useful tool to detect and semiquantify bioactive hepcidin in serum.<\/jats:p>","DOI":"10.1182\/blood-2005-10-4043","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T21:36:38Z","timestamp":1145396198000},"page":"1381-1387","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":217,"title":["Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System"],"prefix":"10.1182","volume":"108","author":[{"given":"Naohisa","family":"Tomosugi","sequence":"first","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawabata","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Wakatabe","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Higuchi","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yamaya","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Umehara","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa; the Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University; the Ciphergen Biosystems, Biomarker Discovery Center, Yokohama; the Department of Toxin, Chugai Pharma, Shizuoka; and the Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711124306500_REF1","doi-asserted-by":"crossref","unstructured":"Andrews NC. Molecular control of iron metabolism. Best Pract Res Clin Haematol. 2005;18: 159-169.","DOI":"10.1016\/j.beha.2004.10.004"},{"key":"2019111711124306500_REF2","doi-asserted-by":"crossref","unstructured":"Philpott CC. Molecular aspects of iron absorption: insights into the role of HFE in hemochromatosis. Hepatology. 2002;35: 993-1001.","DOI":"10.1053\/jhep.2002.33466"},{"key":"2019111711124306500_REF3","doi-asserted-by":"crossref","unstructured":"Fleming RE. Advances in understanding the molecular basis for the regulation of dietary iron absorption. Curr Opin Gastroenterol. 2005;21: 201-206.","DOI":"10.1097\/01.mog.0000153362.98276.db"},{"key":"2019111711124306500_REF4","doi-asserted-by":"crossref","unstructured":"Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102: 783-788.","DOI":"10.1182\/blood-2003-03-0672"},{"key":"2019111711124306500_REF5","doi-asserted-by":"crossref","unstructured":"Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13: 399-408.","DOI":"10.1038\/ng0896-399"},{"key":"2019111711124306500_REF6","doi-asserted-by":"crossref","unstructured":"Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36: 77-82.","DOI":"10.1038\/ng1274"},{"key":"2019111711124306500_REF7","doi-asserted-by":"crossref","unstructured":"Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276: 7811-7819.","DOI":"10.1074\/jbc.M008923200"},{"key":"2019111711124306500_REF8","doi-asserted-by":"crossref","unstructured":"Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276: 7806-7810.","DOI":"10.1074\/jbc.M008922200"},{"key":"2019111711124306500_REF9","doi-asserted-by":"crossref","unstructured":"Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480: 147-150.","DOI":"10.1016\/S0014-5793(00)01920-7"},{"key":"2019111711124306500_REF10","doi-asserted-by":"crossref","unstructured":"Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110: 1037-1044.","DOI":"10.1172\/JCI0215686"},{"key":"2019111711124306500_REF11","doi-asserted-by":"crossref","unstructured":"Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101: 2461-2463.","DOI":"10.1182\/blood-2002-10-3235"},{"key":"2019111711124306500_REF12","doi-asserted-by":"crossref","unstructured":"Kemna E, Tjalsma H, Laarakkers C, et al. Novel urine hepcidin assay by mass spectrometry. Blood. 2005;106: 3268-3270.","DOI":"10.1182\/blood-2005-05-1873"},{"issue":"suppl 3","key":"2019111711124306500_REF13","first-page":"S192","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"2019111711124306500_REF14","first-page":"3","volume":"9","year":"1989","journal-title":"Semin Nephrol"},{"key":"2019111711124306500_REF15","doi-asserted-by":"crossref","unstructured":"Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359: 572-577.","DOI":"10.1016\/S0140-6736(02)07746-2"},{"key":"2019111711124306500_REF16","doi-asserted-by":"crossref","unstructured":"Sanchez JC, Guillaume E, Lescuyer P, et al. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2004;4: 2229-2233.","DOI":"10.1002\/pmic.200300799"},{"key":"2019111711124306500_REF17","doi-asserted-by":"crossref","unstructured":"Stanley BA, Gundry RL, Cotter RJ, et al. Heart disease, clinical proteomics and mass spectrometry. Dis Markers. 2004;20: 167-178.","DOI":"10.1155\/2004\/965261"},{"key":"2019111711124306500_REF18","doi-asserted-by":"crossref","unstructured":"Tomosugi N, Kitagawa K, Takahashi N, et al. Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J Proteome Res. 2005;4: 820-825.","DOI":"10.1021\/pr0497576"},{"key":"2019111711124306500_REF19","unstructured":"Swiss Institute for Bioinformatics and European Bioinformatics Institute. Swiss-Prot Protein Knowledgebase. http:\/\/www.ebi.ac.uk\/swissprot\/. Accessed June 15, 2005."},{"key":"2019111711124306500_REF20","doi-asserted-by":"crossref","unstructured":"Ganz T. Hepcidin: a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 2005;18: 171-182.","DOI":"10.1016\/j.beha.2004.08.020"},{"key":"2019111711124306500_REF21","doi-asserted-by":"crossref","unstructured":"Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113: 1271-1276.","DOI":"10.1172\/JCI200420945"},{"key":"2019111711124306500_REF22","doi-asserted-by":"crossref","unstructured":"Hunter HN, Fulton DB, Ganz T, et al. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem. 2002;277: 37597-37603.","DOI":"10.1074\/jbc.M205305200"},{"key":"2019111711124306500_REF23","doi-asserted-by":"crossref","unstructured":"Taes YE, Wuyts B, Boelaert JR, et al. Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med. 2004;42: 387-389.","DOI":"10.1515\/CCLM.2004.069"},{"key":"2019111711124306500_REF24","doi-asserted-by":"crossref","unstructured":"Kulaksiz H, Gehrke SG, Janetzko A, et al. Prohepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004;53: 735-743.","DOI":"10.1136\/gut.2003.022863"},{"key":"2019111711124306500_REF25","doi-asserted-by":"crossref","unstructured":"Rivera S, Nemeth E, Gabayan V, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106: 2196-2199.","DOI":"10.1182\/blood-2005-04-1766"},{"key":"2019111711124306500_REF26","doi-asserted-by":"crossref","unstructured":"Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J Haematol. 2003;122: 996-1000.","DOI":"10.1046\/j.1365-2141.2003.04516.x"},{"key":"2019111711124306500_REF27","doi-asserted-by":"crossref","unstructured":"Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol. 2005;184: 361-370.","DOI":"10.1677\/joe.1.05729"},{"key":"2019111711124306500_REF28","doi-asserted-by":"crossref","unstructured":"Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A. 2005;102: 1906-1910.","DOI":"10.1073\/pnas.0409808102"},{"key":"2019111711124306500_REF29","doi-asserted-by":"crossref","unstructured":"Lee P, Peng H, Gelbart T, et al. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A. 2004;101: 9263-9265.","DOI":"10.1073\/pnas.0403108101"},{"key":"2019111711124306500_REF30","doi-asserted-by":"crossref","unstructured":"Kawabata H, Fleming RE, Gui D, et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood. 2005;105: 376-381.","DOI":"10.1182\/blood-2004-04-1416"},{"key":"2019111711124306500_REF31","doi-asserted-by":"crossref","unstructured":"Rogers JT. Ferritin translation by interleukin-1 and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood. 1996;87: 2525-2537.","DOI":"10.1182\/blood.V87.6.2525.bloodjournal8762525"},{"key":"2019111711124306500_REF32","doi-asserted-by":"crossref","unstructured":"Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99: 3505-3516.","DOI":"10.1182\/blood.V99.10.3505"},{"key":"2019111711124306500_REF33","doi-asserted-by":"crossref","unstructured":"Tirumalai RS, Chan KC, Prieto DA, et al. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003;2: 1096-1103.","DOI":"10.1074\/mcp.M300031-MCP200"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/4\/1381\/1282309\/zh801606001381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/4\/1381\/1282309\/zh801606001381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T11:12:56Z","timestamp":1573989176000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/108\/4\/1381\/22392\/Detection-of-serum-hepcidin-in-renal-failure-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-10-4043","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]}}}